New Data on Cardiovascular Effects of Glucagon- Like Peptide-1 Receptor Agonists

Anastasios Tentolouris, Ioanna Eleftheriadou and Nikolaos Tentolouris
Additional contact information
Anastasios Tentolouris: Department... to First Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece
Ioanna Eleftheriadou: Department... to First Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece
Nikolaos Tentolouris: Department... to First Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece

Current Research in Diabetes & Obesity Journal, 2017, vol. 2, issue 1, 3-6

Abstract: Cardiovascular disease (CV) is the leading cause of morbidity and mortality in patients with type 2 diabetes. Glucagon-like peptide-1 receptor agonists are new agents that are very promising because they affect many cardiovascular risk factors, apart from improving the glycemic control. Based on the published LEADER and SUSTAIN-6 trials liraglutide and semaglutide have shown cardiovascular benefit and could be reasonable options as second line agents for patients with CV disease.

Keywords: juniper publishers; diabetes journals; diabetes impact factor; endocrinology journal; endocrinology impact factor; endocrinology research journal; endocrinology research articles; diabetes open access journals; Obesity Journal; Diabetes & Obesity Journal (search for similar items in EconPapers)
Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/crdoj/pdf/CRDOJ.MS.ID.55557.pdf (application/pdf)
https://juniperpublishers.com/crdoj/CRDOJ.MS.ID.55557.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jcrdoj:v:2:y:2017:i:1:p:3-6

DOI: 10.19080/CRDOJ.2017.02.55557

Access Statistics for this article

Current Research in Diabetes & Obesity Journal is currently edited by Sophia Mathis

More articles in Current Research in Diabetes & Obesity Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().